GlassScriptPhysician profile
Ellen Lynne Carey
NPI 1740382605
$3,697.94
in general payments reported to CMS, 2019-2025
40 companies · $630 in 2025
The $630 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,016 · 2022: $794 · 2023: $718 · 2024: $540 · 2025: $630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,888.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $640.28 | 2021-2025 | |
| Novo Nordisk INC | $468.16 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $264.02 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $262.35 | 2021-2025 | Zerbaxa, Gardasil 9, Capvaxive |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $252.52 | 2021-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $224.59 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $189.24 | 2021-2024 | Shingrix, Trelegy Ellipta |
| Exact Sciences Corporation | $142.87 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $133.19 | 2021-2024 | Veozah |
| Astrazeneca Pharmaceuticals LP | $89.81 | 2022-2025 | Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $76.31 | 2022 | |
| Alfasigma USA, INC. | $67.80 | 2021 | |
| Novartis Pharmaceuticals Corporation | $67.28 | 2021-2022 | |
| Biofire Diagnostics, LLC | $58.67 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $54.73 | 2021-2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $50.91 | 2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.41 | 2022-2024 | Jardiance |
| Jazz Pharmaceuticals INC. | $44.76 | 2021-2022 | |
| Almatica Pharma LLC | $44.19 | 2021 | |
| Abbott Laboratories | $43.29 | 2021-2022 | |
| Inspire Medical Systems, INC. | $38.55 | 2024-2025 | Inspire |
| Vertex Pharmaceuticals Incorporated | $33.35 | 2025 | |
| Amgen INC. | $32.98 | 2021-2022 | |
| Grifols USA, LLC | $32.40 | 2021-2023 | Prolastin-C Liquid |
| Ucb, INC. | $31.61 | 2023 | Briviact |
| Amarin Pharma, INC. | $29.61 | 2021 | |
| Mayne Pharma Commercial LLC | $29.41 | 2022 | |
| Shield Therapeutics INC | $28.37 | 2023 | Accrufer |
| Vbi Vaccine (Delaware) INC. | $26.28 | 2023 | Prehevbrio |
| Seqirus USA INC | $23.18 | 2025 | Fluad, Flucelvax |
| Daiichi Sankyo INC. | $22.31 | 2021 | |
| Genentech USA, INC. | $19.86 | 2021 | |
| Sumitomo Pharma America, INC. | $18.81 | 2025 | Gemtesa |
| Janssen Pharmaceuticals, INC | $18.74 | 2021 | |
| Dynavax Technologies Corporation | $18.46 | 2023 | Heplisav-B |
| Sanofi Pasteur INC. | $17.07 | 2023 | |
| Indivior INC. | $16.41 | 2025 | Sublocade |
| Boston Scientific Corporation | $14.66 | 2025 | Watchman Flx |
| Molnlycke Health Care US, LLC | $12.85 | 2021 | |
| Inogen, INC. | $10.65 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Carey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.